Alanosine Explained

Alanosine (also called SDX-102)[1] is a substance that has been studied for the treatment of pancreatic cancer.[2] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.

Notes and References

  1. Web site: PubChem. Alanosine. 2021-04-08. pubchem.ncbi.nlm.nih.gov. en.
  2. Yu J . Alanosine (UCSD) . Current Opinion in Investigational Drugs . 2 . 11 . 1623–30 . November 2001 . 11763167 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alanosine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.